Taurine suppresses oxidative stress-potentiated expression of lectin-like oxidized low-density lipoprotein receptor and restenosis in balloon-injured rabbit iliac artery

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 12, 2011, Pages 811-818

  Gokce, G ^a   Ozsarlak Sozer, G ^a   Oran, I ^b   Oktay, G ^c   Ozkal, S ^c   Kerry, Z ^a  

^a Faculty of Pharmacy   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Balloon injury; Glutathione; Lectin like oxidized low density lipoprotein receptor (LOX 1); Restenosis; Taurine

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BUTHIONINE SULFOXIMINE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PLACEBO; TAURINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ILIAC ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RABBIT; RESTENOSIS;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; BUTHIONINE SULFOXIMINE; ENZYME INHIBITORS; ILIAC ARTERY; MALE; OXIDATIVE STRESS; RABBITS; SCAVENGER RECEPTORS, CLASS E; TAURINE; TUNICA INTIMA; TUNICA MEDIA;

EID: 82355183531     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05612.x     Document Type: Article

References (50)

1. Yao EH, Fukuda N, Ueno T et al. Novel gene silencer pyrrole-imidazole polyamide targeting lectin-like oxidized low-density lipoprotein receptor-1 attenuates restenosis of the artery after injury. Hypertension 2008; 52: 86-92.
2. Sawamura T, Kume N, Aoyama T et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386: 73-7.
3. Chen M, Kakutani M, Naruko T et al. Activation-dependent surface expression of LOX-1 in human platelets. Biochem. Biophys. Res. Commun. 2001; 282: 153-8.
4. Kataoka H, Kume N, Miyamoto S et al. Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2001; 21: 955-60.
5. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem. J. 1998; 334: 9-13.
6. Chen XP, Du TT, Zhang GH. Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Cardiovasc. Drug Rev. 2007; 25: 146-61.
7. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. The lectin-like oxidized low-density-lipoprotein receptor: A pro-inflammatory factor in vascular disease. Biochem. J. 2008; 409: 349-55.
8. Chen M, Kakutani M, Minami M et al. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1107-15.
9. Ogura S, Kakino A, Sato Y et al. Lox-1: The multifunctional receptor underlying cardiovascular dysfunction. Circ. J. 2009; 73: 1993-9.
10. Hinagata J, Kakutani M, Fujii T et al. Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc. Res. 2006; 69: 263-71.
11. Anderson ME. Glutathione: An overview of biosynthesis and modulation. Chem. Biol. Interact. 1998; 112: 1-14.
12. Lu SC. Regulation of glutathione synthesis. Curr. Top. Cell. Regul. 2000; 36: 95-116.
13. Gokce G, Ozsarlak-Sozer G, Oktay G et al. Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo. Biochemistry 2009; 48: 4980-7.
14. Cattan V, Mercier N, Gardner JP et al. Chronic oxidative stress induces a tissue-specific reduction in telomere length in CAST/Ei mice. Free Radic. Biol. Med. 2008; 44: 1592-8.
15. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000; 36: 142-6.
16. Tan B, Jiang DJ, Huang H et al. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vasc. Pharmacol. 2007; 46: 338-45.
17. Wang LJ, Yu YH, Zhang LG et al. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: Correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. Eur. J. Pharmacol. 2008; 597: 75-80.
18. Murakami S, Sakurai T, Toda Y, Morito A, Sakono M, Fukuda N. Prevention of neointima formation by taurine ingestion after carotid balloon injury. Vasc. Pharmacol. 2010; 53: 177-84.
19. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 1994; 75: 650-8.
20. Orlandi A, Marcellini M, Pesce D, Calvani M, Spagnoli LG. Propionyl-l-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. Atherosclerosis 2002; 160: 81-9.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-8.
22. Watanabe T, Sagisaka H, Arakawa S et al. A novel model of continuous depletion of glutathione in mice treated with 1-buthionine (S, R)-sulfoximine. J. Toxicol. Sci. 2003; 28: 455-69.
23. Limon-Pacheco JH, Hernandez NA, Fanjul-Moles ML, Gonsebatt ME. Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice. Free Radic. Biol. Med. 2007; 43: 1335-47.
24. Ganafa AA, Socci RR, Eatman D, Silvestrova N, Abukhalaf IK, Bayorh MA. Acute inhibition of glutathione biosynthesis alters endothelial function and blood pressure in rats. Eur. J. Pharmacol. 2002; 454: 217-23.
25. Iwata C, Wang X, Uchida K, Nakanishi N, Hattori Y. Buthionine sulfoximine causes endothelium dependent hyper-relaxation and hypoadiponectinemia. Life Sci. 2007; 80: 873-8.
26. Hashimoto K, Takasaki W, Yamoto T, Manabe S, Sato I, Tsuda S. Effect of glutathione (GSH) depletion on DNA damage and blood chemistry in aged and young rats. J. Toxicol. Sci. 2008; 33: 421-9.
27. Haramaki N, Ikeda H, Takajo Y et al. Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione. Arterioscler. Thromb. Vasc. Biol. 2001; 21: 1852-6.
28. Yildirim Z, Kilic N, Ozer C, Babul A, Take G, Erdogan D. Effects of taurine in cellular responses to oxidative stress in young and middle-aged rat liver. Ann. NY Acad. Sci. 2007; 1100: 553-61.
29. Hu J, Xu X, Yang J, Wu G, Sun C, Lv Q. Antihypertensive effect of taurine in rat. Adv. Exp. Med. Biol. 2009; 643: 75-84.
30. Hagar HH, El Etter E, Arafa M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin. Exp. Pharmacol. Physiol. 2006; 33: 189-96.
31. Azevedo LC, Pedro MA, Souza LC et al. Oxidative stress as a signaling mechanism of the vascular response to injury: The redox hypothesis of restenosis. Cardiovasc. Res. 2000; 47: 436-45.
32. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM, Ozaki CK. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 2000; 102: 1697-702.
33. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J. Clin. Invest. 1994; 93: 1172-8.
34. Laporte S, Escher E. Neointima formation after vascular injury is angiotensin II mediated. Biochem. Biophys. Res. Commun. 1992; 187: 1510-16.
35. Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 2002; 163: 79-87.
36. Zulli A, Lau E, Wijaya BP et al. High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: Association with reduced CCAAT/enhancer binding protein homologous protein and total plasma homocysteine but not lipidemia. Hypertension 2009; 53: 1017-22.
37. Rodriguez-Gomez I, Baca Y, Moreno JM et al. Role of sympathetic tone in BSO-induced hypertension in mice. Am. J. Hypertens. 2010; 23: 882-8.
38. 1 receptor upregulation causes increased stimulation of sodium transporters and hypertension. Am. J. Physiol. Renal Physiol. 2008; 295: F698-706.
39. Sato Y, Ando K, Fujita T. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats. Hypertension 1987; 9: 81-7.
40. Schaffer SW, Lombardini JB, Azuma J. Interaction between the actions of taurine and angiotensin II. Amino Acids 2000; 18: 305-18.
41. Schaffer SW, Solodushko V, Kakhniashvili D. Beneficial effect of taurine depletion on osmotic sodium and calcium loading during chemical hypoxia. Am. J. Physiol. Cell Physiol. 2002; 282: C1113-20.
42. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J. Clin. Invest. 1992; 90: 456-61.
43. Stipanuk MH, Coloso RM, Garcia RA, Banks MF. Cysteine concentration regulates cysteine metabolism to glutathione, sulfate and taurine in rat hepatocytes. J. Nutr. 1992; 122: 420-7.
44. Cantin AM. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport. J. Clin. Invest. 1994; 93: 606-14.
45. Stapleton PP, Redmond HP, Bouchier-Hayes DJ. Taurine and inflammation: A new approach to an old problem? J. Leukoc. Biol. 1997; 61: 231-2.
46. Wright CE, Tallan HH, Lin YY, Gaull GE. Taurine: Biological update. Annu. Rev. Biochem. 1986; 55: 427-53.
47. Gloire G, Legrand-Poels S, Piette J. NF-kappaB activation by reactive oxygen species: Fifteen years later. Biochem. Pharmacol. 2006; 72: 1493-505.
48. Chisolm GM 3rd, Hazen SL, Fox PL, Cathcart MK. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J. Biol. Chem. 1999; 274: 25959-62.
49. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders. Cardiovasc. Res. 2006; 69: 36-45.
50. Murphy JE, Vohra RS, Dunn S et al. Oxidised LDL internalisation by the LOX-1 scavenger receptor is dependent on a novel cytoplasmic motif and is regulated by dynamin-2. J. Cell Sci. 2008; 121: 2136-47.